tradingkey.logo
搜尋

Omnicell Inc

OMCL
添加自選
41.930USD
+0.410+0.99%
收盤 07/01, 16:00美東報價延遲15分鐘
1.91B總市值
94.02本益比TTM

Omnicell Inc

41.930
+0.410+0.99%
查看詳細走勢圖
TradingKey 图表
盤中分時
1分
30分
1小時
日k
週k
月k
日k

今天

+0.99%

5天

+6.18%

1月

-2.85%

6月

-7.44%

今年開始到現在

-7.44%

1年

+40.09%

關鍵數據
41.100今開
43.245最高
511.74K成交量
94.02本益比TTM
18.42本益比動
--股利TTM
1.13%換手率
41.520昨收
41.100最低
18.11M成交額
152.17本益比靜
1.52市淨率
0.00%股息率 TTM
0.98%ROA
55.00052週最高
0.49量比
12.53M淨利潤
45.48M總股本
0.4460每股盈餘TTM
0.97Beta
1.63%ROE
26.84552週最低
5.17%振幅
45.30%毛利率
1.91B總市值
-0.42回報/風險
2.23%風險率

TradingKey Omnicell Inc股票評分

單位: USD 更新時間: 2026-07-01

操作建議

Omnicell Inc當前公司基本面數據相對非常健康,增長潛力很大。當前估值合理,在醫療設備與耗材行業排名27/204位。機構持股佔比非常高,近一月多位分析師給出公司評級為買入。最高目標價為61.29。中期看,股價處於上升通道。近一個月,市場表現一般,但公司基本面和技術面得分較高。目前股價在壓力位和支撐位之間,可以做區間波段操作。

Omnicell Inc評分

相關信息

行業排名
27 / 204
全市場排名
95 / 4564
所屬行業
醫療設備與耗材

壓力支撐

由於公司未披露,未能獲取相關數據

多維評測

本期評分
上期評分

公司輿情

過去24小時
熱度

過冷
過熱
看好

Omnicell Inc亮點

亮點風險
Omnicell, Inc. is a provider of medication management solutions and adherence tools for health systems and pharmacies. The Company is focused on transforming pharmacy care through outcomes-centric innovation designed to optimize clinical and business outcomes across all settings of care through a portfolio of robotics, smart devices, intelligent software, and services. Its point of care automation solutions is designed to improve clinician workflows in patient care areas of the healthcare system, such as nursing units, patient wards, operating rooms, and emergency departments. The Company’s XT Series automated dispensing systems for medications and supplies, which are used in nursing units and other clinical areas of the hospital, are designed to support workflows specific to each area of the hospital, with various software and hardware options. For the operating room, the Company also offer specialized automated dispensing systems.
估值高估
公司最新PE估值94.02,處於3年歷史高位
機構減倉
最新機構持股54.18M股,環比減少0.38%
HACAX持倉
明星投資者HACAX持倉,最新持倉9.44K股
活躍度增加
近期活躍度增加,過去20天平均換手率0.36

分析師目標

基於 8 分析師
買入
評級
61.286
目標均價
+47.61%
漲幅空間

Omnicell Inc新聞

即將為您帶來更多新聞,敬請期待。 。 。

財務指標

每股收益

由於公司未披露,未能獲取相關數據

營業總收入

由於公司未披露,未能獲取相關數據

Omnicell Inc簡介

Omnicell, Inc. is a provider of medication management solutions and adherence tools for health systems and pharmacies. The Company is focused on transforming pharmacy care through outcomes-centric innovation designed to optimize clinical and business outcomes across all settings of care through a portfolio of robotics, smart devices, intelligent software, and services. Its point of care automation solutions is designed to improve clinician workflows in patient care areas of the healthcare system, such as nursing units, patient wards, operating rooms, and emergency departments. The Company’s XT Series automated dispensing systems for medications and supplies, which are used in nursing units and other clinical areas of the hospital, are designed to support workflows specific to each area of the hospital, with various software and hardware options. For the operating room, the Company also offer specialized automated dispensing systems.
公司代碼OMCL
公司Omnicell Inc
CEOLipps (Randall A)
網址https://www.omnicell.com/

常見問題

Omnicell Inc(OMCL)的當前股價是多少?

Omnicell Inc(OMCL)的當前股價是 41.93。

Omnicell Inc 的股票代碼是什麼?

Omnicell Inc的股票代碼是OMCL。

Omnicell Inc股票的52週最高點是多少?

Omnicell Inc股票的52週最高點是55.00。

Omnicell Inc股票的52週最低點是多少?

Omnicell Inc股票的52週最低點是26.84。

Omnicell Inc的市值是多少?

Omnicell Inc的市值是1.91B。

現在Omnicell Inc(OMCL)的股票是買入、持有還是賣出?

根據分析師評級,Omnicell Inc(OMCL)的總體評級為買入,目標價格為61.29。

Omnicell Inc(OMCL)股票的每股收益(EPS TTM)是多少

Omnicell Inc(OMCL)股票的每股收益(EPS TTM)是0.04。